CN Patent

CN111320609A — 一种THRβ受体激动剂化合物及其制备方法和用途

Assigned to Tuozhen Pharmaceutical Co · Expires 2020-06-23 · 6y expired

What this patent protects

本发明公开了一种下式(I)表示的化合物及其药学上可接受的盐。所述化合物在保持其良好的THRβ激动活性的同时改善了对THRα的选择性，从而提高了成药性质。

USPTO Abstract

本发明公开了一种下式(I)表示的化合物及其药学上可接受的盐。所述化合物在保持其良好的THRβ激动活性的同时改善了对THRα的选择性，从而提高了成药性质。

Drugs covered by this patent

Patent Metadata

Patent number
CN111320609A
Jurisdiction
CN
Classification
—
Expires
2020-06-23
Drug substance claim
No
Drug product claim
No
Assignee
Tuozhen Pharmaceutical Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.